Corrigendum: Induction of Robust B Cell Responses After Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells

Gustaf Lindgren^{1

2}, Sebastian Ols^{1

2}, Frank Liang^{1

2}, Elizabeth A Thompson^{1

2}, Ang Lin^{1

2}, Fredrika Hellgren^{1

2}, Kapil Bahl³, Shinu John³, Olga Yuzhakov³, Kimberly J Hassett³, Luis A Brito⁴, Hugh Salter^{4

5}, Giuseppe Ciaramella³, Karin Loré^{1

2}

Affiliations

¹ Department of Medicine Solna, Immunology and Allergy Unit, Karolinska Institutet, Stockholm, Sweden.
² Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
³ Valera LLC, Cambridge, MA, United States.
⁴ Moderna Therapeutics, Cambridge, MA, United States.
⁵ Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Published Erratum

Gustaf Lindgren et al. Front Immunol. 2019.

. 2019 Apr 2:10:614.

doi: 10.3389/fimmu.2019.00614. eCollection 2019.

¹ Department of Medicine Solna, Immunology and Allergy Unit, Karolinska Institutet, Stockholm, Sweden.
² Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
³ Valera LLC, Cambridge, MA, United States.
⁴ Moderna Therapeutics, Cambridge, MA, United States.
⁵ Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2017.01539.].

Keywords: T follicular helper cells; adaptive immune responses; germinal centers; influenza; mRNA vaccine; non-human primates.

Induction of Robust B Cell Responses after Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells.
Lindgren G, Ols S, Liang F, Thompson EA, Lin A, Hellgren F, Bahl K, John S, Yuzhakov O, Hassett KJ, Brito LA, Salter H, Ciaramella G, Loré K. Lindgren G, et al. Front Immunol. 2017 Nov 13;8:1539. doi: 10.3389/fimmu.2017.01539. eCollection 2017. Front Immunol. 2017. PMID: 29181005 Free PMC article.

A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses.
Lenart K, Hellgren F, Ols S, Yan X, Cagigi A, Cerveira RA, Winge I, Hanczak J, Mueller SO, Jasny E, Schwendt K, Rauch S, Petsch B, Loré K. Lenart K, et al. Mol Ther Methods Clin Dev. 2022 Dec 8;27:309-323. doi: 10.1016/j.omtm.2022.10.001. Epub 2022 Oct 6. Mol Ther Methods Clin Dev. 2022. PMID: 36217434 Free PMC article.
Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza.
Chivukula S, Plitnik T, Tibbitts T, Karve S, Dias A, Zhang D, Goldman R, Gopani H, Khanmohammed A, Sarode A, Cooper D, Yoon H, Kim Y, Yan Y, Mundle ST, Groppo R, Beauvais A, Zhang J, Anosova NG, Lai C, Li L, Ulinski G, Piepenhagen P, DiNapoli J, Kalnin KV, Landolfi V, Swearingen R, Fu TM, DeRosa F, Casimiro D. Chivukula S, et al. NPJ Vaccines. 2021 Dec 16;6(1):153. doi: 10.1038/s41541-021-00420-6. NPJ Vaccines. 2021. PMID: 34916519 Free PMC article.
Current progress in the development of prophylactic and therapeutic vaccines.
Li T, Qian C, Gu Y, Zhang J, Li S, Xia N. Li T, et al. Sci China Life Sci. 2023 Apr;66(4):679-710. doi: 10.1007/s11427-022-2230-4. Epub 2022 Dec 2. Sci China Life Sci. 2023. PMID: 36469218 Free PMC article. Review.

1. Trombetta CM, Perini D, Mather S, Temperton N, Montomoli E. Overview of serological techniques for influenza vaccine evaluation: past, present and future. Vaccines (Basel) (2014) 2:707–34. 10.3390/vaccines2040707 - DOI - PMC - PubMed
1. Liang F, Lindgren G, Lin A, Thompson EA, Ols S, et al. . Efficient targeting and activation of antigen presenting cells in vivo after modified mRNA vaccine administration in rhesus macaques. Mol Ther. (2017) 25:2635–47. 10.1016/j.ymthe.2017.08.006 - DOI - PMC - PubMed